跳转至内容
Merck

311383

Sigma-Aldrich

氧化砷(III)

ACS reagent (primary standard)

别名:

三氧化二砷, 亚砷酸

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
As2O3
CAS号:
分子量:
197.84
EC號碼:
MDL號碼:
分類程式碼代碼:
12171602
PubChem物質ID:
NACRES:
NB.24

等級

ACS reagent (primary standard)

品質等級

蒸汽壓力

0 hPa ( 66 °C)

化驗

99.95-100.05%

形狀

powder

反應適用性

reagent type: catalyst
core: arsenic

燃燒殘留物

≤0.02%

溶解度

dilute HCl: insoluble ≤0.01%

負離子痕跡

S2-: passes test (lim. ~0.001%)
chloride (Cl-): ≤0.005%

正離子痕跡

Fe: ≤5 ppm
Pb: ≤0.002%
Sb: ≤0.05%

SMILES 字串

O=[As]O[As]=O

InChI

1S/As2O3/c3-1-5-2-4

InChI 密鑰

IKWTVSLWAPBBKU-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

氧化砷(III),也称为三氧化二砷,是一种可用作合成多种砷基化合物原料的两性氧化物。

應用

氧化砷(III)可用于:
  • 在封闭体系中通过静态氟化法合成五氟化砷(AsF5)。
  • 在醋酸锌、2-甲氧基乙醇和单乙醇胺中加入As2O3,通过溶胶-凝胶自旋涂覆法制备砷掺杂 ZnO 薄膜。

訊號詞

Danger

危險分類

Acute Tox. 2 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 1A - Eye Dam. 1 - Skin Corr. 1B - STOT RE 1

標靶器官

Respiratory system,Cardio-vascular system,Gastrointestinal tract

儲存類別代碼

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Yanfei Jia et al.
PloS one, 8(1), e54774-e54774 (2013-02-06)
Alpha-fetoprotein (AFP)-producing gastric cancer (AFPGC), represented by the production of AFP, has a more aggressive behavior than common gastric cancer. The underlying mechanisms are not well understood. Arsenic trioxide (As(2)O(3)) is used clinically to treat acute promyelocytic leukemia(APL) and has
Liangchun Hao et al.
Journal of pediatric hematology/oncology, 35(2), e67-e70 (2013-02-16)
The aim of this study was to investigate the hepatotoxicity induced by arsenic trioxide (As2O3) at a therapeutic dose for pediatric acute promyelocytic leukemia (APL). A total of APL patients received As2O3 treatment by IV drip. Hepatotoxicity was monitored based
Yuhua Fan et al.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 31(1), 80-91 (2013-02-01)
Arsenic trioxide (As2O3) is a highly effective agent for treatment of acute promyelocytic leukemia (APL). However, consecutively administered As2O3 induces serious adverse cardiac effects, including long QT syndrome (LQTs) and even sudden cardiac death. Previous studies have shown that genistein
Huihui Wang et al.
Environmental toxicology, 28(5), 267-275 (2013-04-17)
Although arsenic is effective in the treatment of acute promyelocytic leukemia (APL), as a well-known environmental toxicant, the side effects of arsenic treatment and arsenic methylation metabolism of the patients are rarely reported. In this manuscript, we investigated 23 APL
Athena Kritharis et al.
Annals of hematology, 92(6), 719-730 (2013-03-16)
For more than 2,000 years, arsenic and its derivatives have shown medical utility. Owing to the toxicities and potential carcinogenicity of arsenicals, their popularity has fluctuated. The exact mechanism of action of therapeutic arsenic is not well characterized but likely

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门